Back
Akero Therapeutics Vs. CVS Health Industry Stock Comparison
Sell
38
AKRO
Akero Therapeutics
Last Price:
20.71
Seasonality Move:
17.5%
Sell
41
CVS
CVS Health
Last Price:
57.54
Seasonality Move:
2.18%
Sell
38
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.73. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
CVS Health (CVS)
is a Sell
Is CVS Health a Buy, Sell or Hold?
- The current CVS Health [CVS] share price is $57.52. The Score for CVS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $57.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 47.07 | Sell |
| Chaikin Money Flow: | 20931 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.79 - 21.55) | Buy |
| Bollinger Bands (100): | (20.13 - 26.01) | Sell |
CVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.05 | Sell |
| Relative Strength Index (14 RSI): | 31.26 | Sell |
| Chaikin Money Flow: | 9913749 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.19 - 68.75) | Sell |
| Bollinger Bands (100): | (65.71 - 79.91) | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.78 | Sell |
| 20-day SMA: | 20.44 | Buy |
| 50-day SMA: | 23.08 | Sell |
| 200-day SMA: | 27.2 | Sell |
| 8-day EMA: | 20.66 | Buy |
| 20-day EMA: | 20.89 | Sell |
| 50-day EMA: | 22 | Sell |
| 200-day EMA: | 26.54 | Sell |
CVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.05 | Buy |
| 20-day SMA: | 60.85 | Sell |
| 50-day SMA: | 69.3 | Sell |
| 200-day SMA: | 71.55 | Sell |
| 8-day EMA: | 56.91 | Buy |
| 20-day EMA: | 60.31 | Sell |
| 50-day EMA: | 66.3 | Sell |
| 200-day EMA: | 72.19 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.06 per share, and a decrease next year of $0.47 per share.
CVS Health Earnings Growth & CVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.61 per share, and an increase next year of $1.04 per share.
Akero Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CVS Health Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||